Advertisement
Advertisement

SILO

SILO logo

Silo Pharma, Inc. Common Stock

6.22
USD
Sponsored
-0.02
-0.32%
Jun 24, 15:58 UTC -4
Closed
exchange

After-Market

5.96

-0.26
-4.26%

Silo Pharma, Inc. Common Stock Profile

About

Silo Pharma. Inc. is a development-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer's, and other rare neurological disorders. Silo Pharma. Inc. is based in ENGLEWOOD CLIFFS, NJ.

Info & Links

CEO

Eric Weisblum

Headquarters

677 N. WASHINGTON BLVD
SARASOTA, FL 34236, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://silopharma.com

Auditor

Salberg & Company, P.A.

Share holders

96

Employees

3

Silo Pharma, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

6.46M

Enterprise Value

2.56M

Enterprise Value/EBITDA(ttm)

-0.54

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

81.83

Price to Book(mrq)

0.88

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

38.57%

Operating Margin(ttm)

-5870.83%

Profit Margin(ttm)

-5863.51%

Return on Equity(ttm)

-83.53%

Return on Invested Capital(ttm)

-86.36%

Return on Assets(ttm)

-63.70%

Income Statement

Revenue(ttm)

72.00K

Revenue Per Share(ttm)

0.07

Gross Profit(ttm)

8.50K

EBITDA(ttm)3

-4.74M

Net Income Available to Common(ttm)

-4.84M

Diluted EPS(ttm)

-0.54

Share Statistics

Beta (5Y Monthly)

0.35

52-Week Change

-31.28%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.08M

Dividend Yield

0.00%

Float4

13.85M

% Held by Insiders

2.22%

% Held by Institutions

5.58%

Balance Sheet

Total Cash(mrq)

6.03M

Total Cash Per Share(mrq)

5.56

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

11.36%

Quick Ratio(mrq)

11.37%

Book Value Per Share(mrq)

0.47

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.56

Free Cash Flow(ytd)

-4.66M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement